In 2011, instead of viewing the FDA as a blocker, G-Tech's founder believed the widespread adoption of technologies like Bluetooth in smartphones would make medical wearables inevitable, forcing regulatory bodies to create pathways for their approval.

Creating a new hardware category in a regulated space like aviation requires more than capital; it demands proactive government engagement to write new laws. Archer initiated efforts to establish the regulatory framework for its eVTOL aircraft, demonstrating the necessity of shaping policy for market creation.

Robinhood CEO Vlad Tenev revealed prediction markets were a distant "2026 plan" until a Supreme Court decision legalized presidential betting. This single regulatory catalyst prompted Robinhood to rush the product to market, where it became a massive success, showing how external events can dramatically accelerate product adoption.

Seeing Machines, a leader in a DMS technology duopoly, is trading at a low forward free cash flow multiple. This is happening just as European regulations make its product mandatory in all new cars, creating an inflection point with huge operating leverage where new revenue flows directly to the bottom line.

Samsara capitalized on the ELD mandate, a government regulation that forced the entire trucking industry to buy electronic logging devices. This tailwind created instant, industry-wide budget for their product, allowing them to rapidly gain market share against incumbents like AT&T and Verizon.

Just as car collectors prize the last models with manual transmissions, the introduction of mandatory surveillance tech will likely create a new class of "vintage" cars: those manufactured just before the mandate, valued for their lack of driver monitoring.

Companies like Amazon (from books to cloud) and Intuitive Surgical (from one specific surgery to many) became massive winners by creating new markets, not just conquering existing ones. Investors should prioritize businesses with the innovative capacity to expand their TAM, as initial market sizes are often misleadingly small.

Regulatory readiness is one of the most underappreciated value drivers in MedTech M&A. An acquirer will pay a premium for a target with a mature regulatory infrastructure, as this "organizational muscle" can save them 2-3 years versus building it from scratch.

Investors err when they size a new market based on its predecessor (e.g., Uber vs. taxis). A fundamental supply-side change creates new capabilities that unlock massive, previously invisible demand, making initial market size calculations dangerously conservative.